Artificial Intelligence (AI) is redefining preventive healthcare by enabling earlier diagnosis, smarter clinical decisions, and wider access to quality medical services. According to K. Chandrasekhar, Co-Founder & CEO, Forus Health, AI-powered diagnostics are accelerating the healthcare industry’s shift from reactive treatment to predictive and preventive care.
“Healthcare is evolving from treating diseases after symptoms appear to identifying risks before they become serious. AI-assisted diagnostics empower clinicians with faster, data-driven insights that support better patient outcomes,” says Chandrasekhar.
One of the biggest advancements is AI-enabled retinal imaging, which is emerging as a powerful tool for detecting both eye disorders and systemic diseases. By analyzing retinal images with machine learning, clinicians can identify subtle patterns that may indicate underlying health risks, improving diagnostic accuracy and enabling timely intervention.
Forus Health is driving this transformation through its 3nethra imaging devices integrated with the FH-POISE AI platform and FHTelecare teleophthalmology solution, extending preventive eye screening to underserved and remote communities.
“The true potential of AI lies in integrating it across the entire continuum of care. At the same time, robust regulatory frameworks, secure data governance, and collaboration between healthcare providers, innovators, and policymakers are essential for responsible adoption,” Chandrasekhar adds.
As AI adoption continues to grow, industry leaders believe it will play a pivotal role in improving healthcare accessibility, reducing diagnostic delays, and building a more patient-centric preventive healthcare ecosystem.
